Related Experiment Video
Updated: May 5, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.3K
Diminished complement-activating capacity through the classical pathway in sera from type 2 diabetes mellitus.
Takayuki Fujita1, Seiichiro Hemmi, Mamiko Kajiwara
1Department of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine , Tokyo , Japan.
Immunological Investigations
|December 6, 2013
Summary
Increased free sialic acid in type 2 diabetes mellitus (T2DM) may reduce complement activation. This study found lower complement activity in T2DM patients, linked to higher sialic acid levels.
Area of Science:
- Immunology
- Metabolic Disorders
Background:
- Type 2 diabetes mellitus (T2DM) is associated with immune dysregulation.
- The complement system plays a role in inflammation and immune responses.
Purpose of the Study:
- To investigate the complement-activating capacity via the classical pathway in T2DM.
- To explore the role of free sialic acid as a modulator of complement activation in T2DM.
Main Methods:
- Incubation study using heat-aggregated IgG (HAG) and sera from 42 T2DM patients.
- In vitro experiments with N-acetyl neuraminic acid (NANA) and normal serum/HAG.
- Isoelectrofocusing analysis of C3 and NANA.
- Fluorometric assay for serum free sialic acid levels.
Main Results:
- Diminished in vitro complement-activating capacity via the classical pathway was observed in T2DM.
- N-acetyl neuraminic acid (NANA) dose-dependently decreased complement activation product levels.
- Increased serum free sialic acid levels correlated with diminished complement activation in T2DM patients.
Conclusions:
- Elevated serum free sialic acid may downregulate complement activation in T2DM.
- Increased sialic acid is a potential candidate for modulating complement activity in T2DM.
- Further research is warranted to explore therapeutic implications.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K